Lactobacillus paracasei GMNL-32 exerts a therapeutic effect on cardiac abnormalities in NZB/W F1 mice

Wei Syun Hu, Peramaiyan Rajendran, Bor Show Tzang, Yu Lan Yeh, Chia Yao Shen, Ray Jade Chen, Tsung Jung Ho, Viswanadha Vijaya Padma, Yi Hsing Chen, Chih Yang Huang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Systemic lupus erythematosus (SLE) is a disease that mostly affects women. Accelerated atherosclerosis is a high-risk factor associated with SLE patients. SLE associated with cardiovascular disease is one of the most important causes of death. In this study, we demonstrated that Lactobacillus paracasei GMNL-32 (GMNL-32), a probiotic species, exhibits anti-fibrosis and anti-apoptotic effects on the cardiac tissue of NZB/WF1 mice. Female NZB/W F1 mice, a well-known and commonly used lupus-prone mouse strain, were treated with or without GMNL-32 administration for 12 weeks. Oral administration of GMNL-32 to NZB/WF1 mice significantly increased the ventricular thickness when compared to that of NZB/WF1 mice. Administration of GMNL-32 significantly attenuated the cardiac cell apoptosis that was observed in exacerbate levels in the control NZB/WF1 mice. Further, the cellular morphology that was slightly distorted in the NZB/WF1 was effectively alleviated in the treatment group mice. In addition, GMNL-32 reduced the level of Fas death receptor-related pathway of apoptosis signaling and enhanced anti-apoptotic proteins. These results indicate that GMNL-32 exhibit an effective protective effect on cardiac cells of SLE mice. Thus, GMNL-32 may be a potential therapeutic strategy against SLE associated arthrosclerosis.

Original languageEnglish
Article numbere0185098
JournalPLoS One
Volume12
Issue number9
DOIs
Publication statusPublished - Sep 1 2017

Fingerprint

Lactobacillus paracasei
Inbred NZB Mouse
Therapeutic Uses
Systemic Lupus Erythematosus
lupus erythematosus
therapeutics
mice
Apoptosis
Death Domain Receptors
Apoptosis Regulatory Proteins
CD95 Antigens
Tissue
Probiotics
apoptosis
Oral Administration
Cause of Death
Atherosclerosis
Fibrosis
Cardiovascular Diseases
atherosclerosis

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Hu, W. S., Rajendran, P., Tzang, B. S., Yeh, Y. L., Shen, C. Y., Chen, R. J., ... Huang, C. Y. (2017). Lactobacillus paracasei GMNL-32 exerts a therapeutic effect on cardiac abnormalities in NZB/W F1 mice. PLoS One, 12(9), [e0185098]. https://doi.org/10.1371/journal.pone.0185098

Lactobacillus paracasei GMNL-32 exerts a therapeutic effect on cardiac abnormalities in NZB/W F1 mice. / Hu, Wei Syun; Rajendran, Peramaiyan; Tzang, Bor Show; Yeh, Yu Lan; Shen, Chia Yao; Chen, Ray Jade; Ho, Tsung Jung; Padma, Viswanadha Vijaya; Chen, Yi Hsing; Huang, Chih Yang.

In: PLoS One, Vol. 12, No. 9, e0185098, 01.09.2017.

Research output: Contribution to journalArticle

Hu, WS, Rajendran, P, Tzang, BS, Yeh, YL, Shen, CY, Chen, RJ, Ho, TJ, Padma, VV, Chen, YH & Huang, CY 2017, 'Lactobacillus paracasei GMNL-32 exerts a therapeutic effect on cardiac abnormalities in NZB/W F1 mice', PLoS One, vol. 12, no. 9, e0185098. https://doi.org/10.1371/journal.pone.0185098
Hu, Wei Syun ; Rajendran, Peramaiyan ; Tzang, Bor Show ; Yeh, Yu Lan ; Shen, Chia Yao ; Chen, Ray Jade ; Ho, Tsung Jung ; Padma, Viswanadha Vijaya ; Chen, Yi Hsing ; Huang, Chih Yang. / Lactobacillus paracasei GMNL-32 exerts a therapeutic effect on cardiac abnormalities in NZB/W F1 mice. In: PLoS One. 2017 ; Vol. 12, No. 9.
@article{4adb320110b541ac97b2709d449e437d,
title = "Lactobacillus paracasei GMNL-32 exerts a therapeutic effect on cardiac abnormalities in NZB/W F1 mice",
abstract = "Systemic lupus erythematosus (SLE) is a disease that mostly affects women. Accelerated atherosclerosis is a high-risk factor associated with SLE patients. SLE associated with cardiovascular disease is one of the most important causes of death. In this study, we demonstrated that Lactobacillus paracasei GMNL-32 (GMNL-32), a probiotic species, exhibits anti-fibrosis and anti-apoptotic effects on the cardiac tissue of NZB/WF1 mice. Female NZB/W F1 mice, a well-known and commonly used lupus-prone mouse strain, were treated with or without GMNL-32 administration for 12 weeks. Oral administration of GMNL-32 to NZB/WF1 mice significantly increased the ventricular thickness when compared to that of NZB/WF1 mice. Administration of GMNL-32 significantly attenuated the cardiac cell apoptosis that was observed in exacerbate levels in the control NZB/WF1 mice. Further, the cellular morphology that was slightly distorted in the NZB/WF1 was effectively alleviated in the treatment group mice. In addition, GMNL-32 reduced the level of Fas death receptor-related pathway of apoptosis signaling and enhanced anti-apoptotic proteins. These results indicate that GMNL-32 exhibit an effective protective effect on cardiac cells of SLE mice. Thus, GMNL-32 may be a potential therapeutic strategy against SLE associated arthrosclerosis.",
author = "Hu, {Wei Syun} and Peramaiyan Rajendran and Tzang, {Bor Show} and Yeh, {Yu Lan} and Shen, {Chia Yao} and Chen, {Ray Jade} and Ho, {Tsung Jung} and Padma, {Viswanadha Vijaya} and Chen, {Yi Hsing} and Huang, {Chih Yang}",
year = "2017",
month = "9",
day = "1",
doi = "10.1371/journal.pone.0185098",
language = "English",
volume = "12",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "9",

}

TY - JOUR

T1 - Lactobacillus paracasei GMNL-32 exerts a therapeutic effect on cardiac abnormalities in NZB/W F1 mice

AU - Hu, Wei Syun

AU - Rajendran, Peramaiyan

AU - Tzang, Bor Show

AU - Yeh, Yu Lan

AU - Shen, Chia Yao

AU - Chen, Ray Jade

AU - Ho, Tsung Jung

AU - Padma, Viswanadha Vijaya

AU - Chen, Yi Hsing

AU - Huang, Chih Yang

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Systemic lupus erythematosus (SLE) is a disease that mostly affects women. Accelerated atherosclerosis is a high-risk factor associated with SLE patients. SLE associated with cardiovascular disease is one of the most important causes of death. In this study, we demonstrated that Lactobacillus paracasei GMNL-32 (GMNL-32), a probiotic species, exhibits anti-fibrosis and anti-apoptotic effects on the cardiac tissue of NZB/WF1 mice. Female NZB/W F1 mice, a well-known and commonly used lupus-prone mouse strain, were treated with or without GMNL-32 administration for 12 weeks. Oral administration of GMNL-32 to NZB/WF1 mice significantly increased the ventricular thickness when compared to that of NZB/WF1 mice. Administration of GMNL-32 significantly attenuated the cardiac cell apoptosis that was observed in exacerbate levels in the control NZB/WF1 mice. Further, the cellular morphology that was slightly distorted in the NZB/WF1 was effectively alleviated in the treatment group mice. In addition, GMNL-32 reduced the level of Fas death receptor-related pathway of apoptosis signaling and enhanced anti-apoptotic proteins. These results indicate that GMNL-32 exhibit an effective protective effect on cardiac cells of SLE mice. Thus, GMNL-32 may be a potential therapeutic strategy against SLE associated arthrosclerosis.

AB - Systemic lupus erythematosus (SLE) is a disease that mostly affects women. Accelerated atherosclerosis is a high-risk factor associated with SLE patients. SLE associated with cardiovascular disease is one of the most important causes of death. In this study, we demonstrated that Lactobacillus paracasei GMNL-32 (GMNL-32), a probiotic species, exhibits anti-fibrosis and anti-apoptotic effects on the cardiac tissue of NZB/WF1 mice. Female NZB/W F1 mice, a well-known and commonly used lupus-prone mouse strain, were treated with or without GMNL-32 administration for 12 weeks. Oral administration of GMNL-32 to NZB/WF1 mice significantly increased the ventricular thickness when compared to that of NZB/WF1 mice. Administration of GMNL-32 significantly attenuated the cardiac cell apoptosis that was observed in exacerbate levels in the control NZB/WF1 mice. Further, the cellular morphology that was slightly distorted in the NZB/WF1 was effectively alleviated in the treatment group mice. In addition, GMNL-32 reduced the level of Fas death receptor-related pathway of apoptosis signaling and enhanced anti-apoptotic proteins. These results indicate that GMNL-32 exhibit an effective protective effect on cardiac cells of SLE mice. Thus, GMNL-32 may be a potential therapeutic strategy against SLE associated arthrosclerosis.

UR - http://www.scopus.com/inward/record.url?scp=85029765763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029765763&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0185098

DO - 10.1371/journal.pone.0185098

M3 - Article

C2 - 28934296

AN - SCOPUS:85029765763

VL - 12

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 9

M1 - e0185098

ER -